Common antidepressant may ease long COVID’s crushing fatigue

Researchers have found that the low-cost antidepressant fluvoxamine may help alleviate long COVID's debilitating fatigue. A randomized clinical trial involving 399 adults showed that fluvoxamine significantly reduced fatigue and improved quality of life compared to a placebo. This discovery makes fluvoxamine one of the first medications to demonstrate substantial benefits for this condition. The findings offer new hope for individuals struggling with long COVID fatigue.

✦ AI-generated summary